Par Drugs and Chemicals Limited — Board Meeting, 10-02-2026: Outcome of Board Meeting
10-02-2026 | 05:23 pm
10-02-2026 | 05:23 pm
PAR Drugs has announced a board meeting where it approved Q3 & 9M financial results. Q3 revenue: Rs 29.34 Cr, profit: Rs 4.80 Cr. 9M revenue: Rs 84.04 Cr, profit: Rs 12.25 Cr. EPS Q3: Rs 3.90, 9M: Rs 9.96.
No comments yet. Be the first to comment!
